» Authors » Maria E Sundaram

Maria E Sundaram

Explore the profile of Maria E Sundaram including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 56
Citations 2211
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
VanWormer J, Alicea G, Weichelt B, Berg R, Sundaram M
Vaccine . 2022 Nov; 41(1):68-75. PMID: 36400661
Background: The risks of severe outcomes associated with SARS-CoV-2 (COVID-19) are elevated in unvaccinated individuals. It remains crucial to understand patterns of COVID-19 vaccination, particularly in younger and remote populations...
12.
Irving S, Sundaram M
Lancet . 2022 Oct; 400(10360):1282-1283. PMID: 36244366
No abstract available.
13.
Chung H, Austin P, Brown K, Buchan S, Fell D, Fong C, et al.
Open Forum Infect Dis . 2022 Sep; 9(9):ofac449. PMID: 36147595
Background: Waning protection from 2 doses of coronavirus disease 2019 (COVID-19) vaccines led to third dose availability in multiple countries even before the emergence of the Omicron variant. Methods: We...
14.
Buchan S, Chung H, Brown K, Austin P, Fell D, Gubbay J, et al.
JAMA Netw Open . 2022 Sep; 5(9):e2232760. PMID: 36136332
Importance: The incidence of SARS-CoV-2 infection, including among individuals who have received 2 doses of COVID-19 vaccine, increased substantially following the emergence of the Omicron variant in Ontario, Canada. Understanding...
15.
Sundaram M, Pamplin 2nd J
Lancet Healthy Longev . 2022 Sep; 2(3):e115-e116. PMID: 36098108
No abstract available.
16.
Sundaram M, Bednarczyk R
J Adolesc Health . 2022 Jun; 71(1):4-5. PMID: 35718390
No abstract available.
17.
Hamilton M, Liu Y, Calzavara A, Sundaram M, Djebli M, Darvin D, et al.
Influenza Other Respir Viruses . 2022 May; 16(6):1072-1081. PMID: 35611399
Background: Shared and divergent predictors of clinical severity across respiratory viruses may support clinical and community responses in the context of a novel respiratory pathogen. Methods: We conducted a retrospective...
18.
Ulrich A, Sundaram M, Basta N
Vaccine . 2022 Mar; 40(14):2123-2125. PMID: 35256221
No abstract available.
19.
20.
Nasreen S, Chung H, He S, Brown K, Gubbay J, Buchan S, et al.
Nat Microbiol . 2022 Feb; 7(3):379-385. PMID: 35132198
SARS-CoV-2 variants of concern (VOC) are more transmissible and may have the potential for increased disease severity and decreased vaccine effectiveness. We estimated the effectiveness of BNT162b2 (Pfizer-BioNTech Comirnaty), mRNA-1273...